title: Benefit of glucocorticosteroid in the routine therapy of bacterial meningitis in children.
abstract: Based on the most recent randomised-controlled studies, meta-analysis, and observational studies, the use of corticosteroids is recommended in most cases of acquired community purulent meningitis in children from industrialised countries, in order to reduce the incidence of severe deafness and likely of other neurological morbidities.
authors.affiliation: Child Neurology Department, CHU de Sherbrooke, Université de Sherbrooke, 3001 12eme avenue Nord, Sherbrooke, Qué., Canada J1H 5N4. Guillaume.Sebire@Usherbrooke.ca
authors.forename: Guillaume
authors.initials: G
authors.lastname: Sébire
authors.forename: Claude
authors.initials: C
authors.lastname: Cyr
authors.forename: Bernard
authors.initials: B
authors.lastname: Echenne
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002648:Child; D003638:Deafness / Q000209:etiology / Q000517:prevention & control; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D016920:Meningitis, Bacterial / Q000150:complications / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids